Concepedia

Dirk Lindenblatt

DL

Statistics

Publications

10

Citations

190

H-Index

10

Active since

2014

Affiliations

University of Cologne(Current)

University of Münster

Saarland University

Warsaw University of Technology

University of Bonn

Dirk Lindenblatt is an author at University of Cologne specializing in medicinal chemistry, pharmacology, and drug design.

ORCID

Publications per year

2014–2022

10

Publications

10

Molecular Plasticity of Crystalline CK2α′ Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity

Dirk Lindenblatt, Violetta Applegate, Anna Nickelsen et al. · Journal of Medicinal Chemistry · 2021 · 29 citations · Full text

, , +17

Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures

Dirk Lindenblatt, Anna Nickelsen, Violetta Applegate et al. · ACS Omega · 2019 · 28 citations · Full text

, , +15

Design of CK2β‐Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells

Dirk Lindenblatt, Mareike Horn, Claudia Götz et al. · ChemMedChem · 2019 · 20 citations

, , +17

De novo variants of CSNK2B cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway

Maria Asif, Emrah Kaygusuz, Marwan Shinawi et al. · Human Genetics and Genomics Advances · 2022 · 20 citations · Full text

, , +17

Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction

Jennifer Hochscherf, Dirk Lindenblatt, Michaela Steinkrüger et al. · Analytical Biochemistry · 2014 · 19 citations

, , +14

1–5 of 10